{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:29:14Z","timestamp":1793730554621,"version":"4.6.1"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008714","name":"Motor Neurone Disease Research Institute of Australia","doi-asserted-by":"publisher","award":["152324"],"award-info":[{"award-number":["152324"]}],"id":[{"id":"10.13039\/100008714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spinal muscular atrophy (SMA) is a neurodegenerative disease that has a substantial and multifaceted burden on affected adults. While advances in supportive care and therapies are rapidly reshaping the therapeutic environment, these efforts have largely centered on pediatric populations. Understanding the natural history, care pathways, and patient-reported outcomes associated with SMA in adulthood is critical to advancing health policy, practice and research across the disease spectrum. The aim of this study was to systematically review research investigating the healthcare, well-being and lived experiences of adults with SMA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In accordance with the Preferred Reported Items for Systematic Reviews and Meta-Analysis guidelines, seven electronic databases were systematically searched until January 2020 for studies examining clinical (physical health, natural history, treatment) and patient-reported (symptoms, physical function, mental health, quality of life, lived experiences) outcomes in adults with SMA. Study risk of bias and the level of evidence were assessed using validated tools.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ninety-five articles met eligibility criteria with clinical and methodological diversity observed across studies. A heterogeneous clinical spectrum with variability in natural history was evident in adults, yet slow declines in motor function were reported when observational periods extended beyond 2 years. There remains no high quality\u00a0evidence of an efficacious drug treatment for adults. Limitations in mobility and daily activities associated with deteriorating physical health were commonly reported, alongside emotional difficulties, fatigue and a perceived lack of societal support, however there was no evidence regarding effective interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This systematic review identifies the many uncertainties regarding best clinical practice, treatment response, and long-term outcomes for adults with SMA. This comprehensive identification of the current gaps in knowledge is essential to guide future clinical research, best practice care, and advance health policy with the ultimate aim of reducing the burden associated with adult SMA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-1339-3","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T13:03:08Z","timestamp":1584018188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review"],"prefix":"10.1186","volume":"15","author":[{"given":"Hamish W. Y.","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate A.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"D\u2019Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Vucic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine A.","family":"Kasparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-0902","authenticated-orcid":false,"given":"Michelle A.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"issue":"3","key":"1339_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197\u2013207.","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"1339_CR2","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22(8):1027\u201349. https:\/\/doi.org\/10.1177\/0883073807305788.","journal-title":"J Child Neurol"},{"issue":"2","key":"1339_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103\u201315.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"1339_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2011.09.001","volume":"46","author":"JA Markowitz","year":"2012","unstructured":"Markowitz JA, Singh P, Darras BT. Spinal muscular atrophy: a clinical and research update. Pediatr Neurol. 2012;46(1):1\u201312. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2011.09.001.","journal-title":"Pediatr Neurol"},{"issue":"18","key":"1339_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723\u201332.","journal-title":"N Engl J Med"},{"key":"1339_CR6","doi-asserted-by":"publisher","unstructured":"Hoy SM. Onasemnogene Abeparvovec: first global approval. Drugs. 2019. https:\/\/doi.org\/10.1007\/s40265-019-01162-5.","DOI":"10.1007\/s40265-019-01162-5"},{"issue":"7","key":"1339_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625\u201335.","journal-title":"N Engl J Med"},{"issue":"4","key":"1339_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40265-017-0711-7","volume":"77","author":"SM Hoy","year":"2017","unstructured":"Hoy SM. Nusinersen: first global approval. Drugs. 2017;77(4):473\u20139. https:\/\/doi.org\/10.1007\/s40265-017-0711-7.","journal-title":"Drugs."},{"issue":"4","key":"1339_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nn.4508","volume":"20","author":"DR Corey","year":"2017","unstructured":"Corey DR. Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. Nat Neurosci. 2017;20(4):497.","journal-title":"Nat Neurosci"},{"issue":"3","key":"1339_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet. 1997;16(3):265.","journal-title":"Nat Genet"},{"issue":"1","key":"1339_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155\u201365.","journal-title":"Cell."},{"issue":"1","key":"1339_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of> 72 400 specimens. Eur J Hum Genet. 2012;20(1):27.","journal-title":"Eur J Hum Genet"},{"key":"1339_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, et al. Prevalence, incidence and carrier frequency of 5q\u2013linked spinal muscular atrophy \u2013 a literature review. Orphanet J Rare Dis. 2017;12:124. https:\/\/doi.org\/10.1186\/s13023-017-0671-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1339_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020907","volume":"8","author":"MA Farrar","year":"2018","unstructured":"Farrar MA, Carey KA, Paguinto S-G, Chambers G, Kasparian NA. Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives. BMJ Open. 2018;8(5):e020907.","journal-title":"BMJ Open"},{"issue":"7","key":"1339_CR15","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","volume":"264","author":"I Verhaart","year":"2017","unstructured":"Verhaart I, Robertson A, Leary R, McMacken G, K\u00f6nig K, Kirschner J, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264(7):1465\u201373. https:\/\/doi.org\/10.1007\/s00415-017-8549-1.","journal-title":"J Neurol"},{"issue":"9","key":"1339_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/gt.2017.56","volume":"24","author":"S Madipalli","year":"2017","unstructured":"Madipalli S. Spinraza\u2014the patient perspective. Gene Ther. 2017;24(9):501.","journal-title":"Gene Ther"},{"issue":"1","key":"1339_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00415-013-7154-1","volume":"261","author":"CL Bladen","year":"2014","unstructured":"Bladen CL, Thompson R, Jackson JM, Garland C, Wegel C, Ambrosini A, et al. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol. 2014;261(1):152\u201363.","journal-title":"J Neurol"},{"issue":"1","key":"1339_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616.","journal-title":"Int J Soc Res Methodol"},{"issue":"1","key":"1339_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"key":"1339_CR20","volume-title":"Standard quality assessment criteria for evaluating primary research papers from a variety of fields","author":"LM Kmet","year":"2004","unstructured":"Kmet LM, Lee RC, Cook LS. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Edmonton: Alberta Heritage Foundation for Medical Research (AHFMR)AHFMR - HTA Initiative #13; 2004."},{"key":"1339_CR21","unstructured":"Oxford Centre for Evidence-Based Medicine. The Oxford 2011 Levels of Evidence.https:\/\/www.cebm.net\/2016\/05\/ocebm-levels-of-evidence\/."},{"issue":"3","key":"1339_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ene.13534","volume":"25","author":"R Wadman","year":"2018","unstructured":"Wadman R, Wijngaarde C, Stam M, Bartels B, Otto L, Lemmink H, et al. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c\u20134. Eur J Neurol. 2018;25(3):512\u20138.","journal-title":"Eur J Neurol"},{"issue":"3","key":"1339_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/jnd-190379","volume":"6","author":"AMB van der Heul","year":"2019","unstructured":"van der Heul AMB, Wijngaarde CA, Wadman RI, Asselman F, van den Aardweg MTA, Bartels B, et al. Bulbar problems self-reported by children and adults with spinal muscular atrophy. J Neuromuscul Dis. 2019;6(3):361\u20138. https:\/\/doi.org\/10.3233\/jnd-190379.","journal-title":"J Neuromuscul Dis"},{"issue":"12","key":"1339_CR24","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/phm.0000000000001258","volume":"98","author":"LHC Peeters","year":"2019","unstructured":"Peeters LHC, Janssen M, Kingma I, van Dieen JH, de Groot IJM. Patients with spinal muscular atrophy use high percentages of trunk muscle capacity to perform seated tasks. Am J Phys Med Rehabil. 2019;98(12):1110\u20137. https:\/\/doi.org\/10.1097\/phm.0000000000001258.","journal-title":"Am J Phys Med Rehabil"},{"issue":"3","key":"1339_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2340\/16501977-0507","volume":"42","author":"A Febrer","year":"2010","unstructured":"Febrer A, Rodriguez N, Alias L, Tizzano E. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy. J Rehabil Med. 2010;42(3):228\u201331.","journal-title":"J Rehabil Med"},{"issue":"9","key":"1339_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1212\/01.wnl.0000324623.89105.c4","volume":"71","author":"F Deymeer","year":"2008","unstructured":"Deymeer F, Serdaroglu P, Parman Y, Poda M. Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude. Neurology. 2008;71(9):644\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000324623.89105.c4.","journal-title":"Neurology."},{"issue":"13","key":"1339_CR27","doi-asserted-by":"publisher","first-page":"e1206","DOI":"10.1212\/wnl.0000000000006241","volume":"91","author":"P Mongiovi","year":"2018","unstructured":"Mongiovi P, Dilek N, Garland C, Hunter M, Kissel JT, Luebbe E, et al. Patient reported impact of symptoms in spinal suscular atrophy (PRISM-SMA). Neurology. 2018;91(13):e1206\u2013e14. https:\/\/doi.org\/10.1212\/wnl.0000000000006241.","journal-title":"Neurology."},{"issue":"1","key":"1339_CR28","first-page":"10","volume":"23","author":"SM Sporer","year":"2003","unstructured":"Sporer SM, Smith BG. Hip dislocation in patients with spinal muscular atrophy. J Pediatr Orthop. 2003;23(1):10\u20134.","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"1339_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-510X(96)00284-5","volume":"146","author":"K Zerres","year":"1997","unstructured":"Zerres K, Rudnik-Schoneborn S, Forrest E, Lusakowska A, Borkowska J, Hausmanowa-Petrusewicz I. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997;146(1):69\u201372.","journal-title":"J Neurol Sci"},{"issue":"5","key":"1339_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"K Zerres","year":"1995","unstructured":"Zerres K, Rudnik-Sch\u00f6neborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52(5):518\u201323.","journal-title":"Arch Neurol"},{"issue":"5","key":"1339_CR31","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1542\/peds.2004-0668","volume":"114","author":"BHY Chung","year":"2004","unstructured":"Chung BHY, Wong VCN, Ip P. Spinal muscular atrophy: survival pattern and functional status. Pediatrics. 2004;114(5):e548\u2013e53. https:\/\/doi.org\/10.1542\/peds.2004-0668.","journal-title":"Pediatrics."},{"issue":"1","key":"1339_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jpeds.2012.05.067","volume":"162","author":"MA Farrar","year":"2013","unstructured":"Farrar MA, Vucic S, Johnston HM, Du Sart D, Kiernan MC. Pathophysiological insights derived by natural history and motor function of spinal muscular atrophy. J Pediatr. 2013;162(1):155\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2012.05.067.","journal-title":"J Pediatr"},{"issue":"9","key":"1339_CR33","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00415-008-0929-0","volume":"255","author":"S Piepers","year":"2008","unstructured":"Piepers S, van den Berg LH, Brugman F, Scheffer H, Ruiterkamp-Versteeg M, van Engelen BG, et al. A natural history study of late onset spinal muscular atrophy types 3b and 4. J Neurol. 2008;255(9):1400\u20134. https:\/\/doi.org\/10.1007\/s00415-008-0929-0.","journal-title":"J Neurol"},{"issue":"18","key":"1339_CR34","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","volume":"79","author":"P Kaufmann","year":"2012","unstructured":"Kaufmann P, McDermott MP, Darras BT, Finkel RS, Sproule DM, Kang PB, et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology. 2012;79(18):1889\u201397.","journal-title":"Neurology"},{"issue":"4","key":"1339_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/mus.26419","volume":"59","author":"MC Pera","year":"2019","unstructured":"Pera MC, Coratti G, Mazzone ES, Montes J, Scoto M, De Sanctis R, et al. Revised upper limb module for spinal muscular atrophy: 12 month changes. Muscle Nerve. 2019;59(4):426\u201330. https:\/\/doi.org\/10.1002\/mus.26419.","journal-title":"Muscle Nerve"},{"issue":"2","key":"1339_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nmd.2015.10.006","volume":"26","author":"E Mercuri","year":"2016","unstructured":"Mercuri E, Finkel R, Montes J, Mazzone ES, Sormani MP, Main M, et al. Patterns of disease progression in type 2 and 3 SMA: implications for clinical trials. Neuromuscul Disord. 2016;26(2):126\u201331.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"1339_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.nmd.2014.11.008","volume":"25","author":"S Sivo","year":"2015","unstructured":"Sivo S, Mazzone E, Antonaci L, De Sanctis R, Fanelli L, Palermo C, et al. Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes. Neuromuscul Disord. 2015;25(3):212\u20135.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"1339_CR38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.nmd.2012.06.352","volume":"22","author":"U Werlauff","year":"2012","unstructured":"Werlauff U, Vissing J, Steffensen B. Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study. Neuromuscul Disord. 2012;22(12):1069\u201374.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"1339_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199657","volume":"13","author":"J Montes","year":"2018","unstructured":"Montes J, McDermott MP, Mirek E, Mazzone ES, Main M, Glanzman AM, et al. Ambulatory function in spinal muscular atrophy: age-related patterns of progression. PLoS One. 2018;13(6):e0199657. https:\/\/doi.org\/10.1371\/journal.pone.0199657.","journal-title":"PLoS One"},{"issue":"8","key":"1339_CR40","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.apmr.2013.01.014","volume":"94","author":"C Vuillerot","year":"2013","unstructured":"Vuillerot C, Payan C, Iwaz J, Ecochard R, B\u00e9rard C, Group MSMAS. Responsiveness of the motor function measure in patients with spinal muscular atrophy. Arch Phys Med Rehabil. 2013;94(8):1555\u201361.","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"1339_CR41","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/WNL.47.4.973","volume":"47","author":"B Russman","year":"1996","unstructured":"Russman B, Buncher C, White M, Samaha F, Iannaccone S. Function changes in spinal muscular atrophy II and III. Neurology. 1996;47(4):973\u20136.","journal-title":"Neurology."},{"issue":"2","key":"1339_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/088307380001500207","volume":"15","author":"ST Iannaccone","year":"2000","unstructured":"Iannaccone ST, Russman BS, Browne RH, Buncher CR, White M, Samaha FJ. Prospective analysis of strength in spinal muscular atrophy. J Child Neurol. 2000;15(2):97\u2013101.","journal-title":"J Child Neurol"},{"issue":"5 Suppl","key":"1339_CR43","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1097\/00002060-199509001-00009","volume":"74","author":"GT Carter","year":"1995","unstructured":"Carter GT, Abresch RT, Fowler JW, Johnson ER, Kilmer DD, McDonald CM. Profiles of neuromuscular diseases. Spinal muscular atrophy. Am J Phys Med Rehabil. 1995;74(5 Suppl):S150\u20139.","journal-title":"Am J Phys Med Rehabil"},{"issue":"5","key":"1339_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/mus.25385","volume":"55","author":"H Durmus","year":"2017","unstructured":"Durmus H, Yilmaz R, Gulsen-Parman Y, Oflazer-Serdaroglu P, Cuttini M, Dursun MU, et al. Muscle magnetic resonance imaging in spinal muscular atrophy type 3: selective and progressive involvement. Muscle Nerve. 2017;55(5):651\u20136. https:\/\/doi.org\/10.1002\/mus.25385.","journal-title":"Muscle Nerve"},{"issue":"1","key":"1339_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nmd.2009.11.008","volume":"20","author":"U Werlauff","year":"2010","unstructured":"Werlauff U, Steffensen B, Bertelsen S, Fl\u00f8ytrup I, Kristensen B, Werge B. Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients. Neuromuscul Disord. 2010;20(1):34\u201343.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"1339_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/mus.20018","volume":"29","author":"L Merlini","year":"2004","unstructured":"Merlini L, Bertini E, Minetti C, Mongini T, Morandi L, Angelini C, et al. Motor function\u2013muscle strength relationship in spinal muscular atrophy. Muscle Nerve. 2004;29(4):548\u201352.","journal-title":"Muscle Nerve"},{"issue":"4","key":"1339_CR47","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/mus.21350","volume":"40","author":"B Elsheikh","year":"2009","unstructured":"Elsheikh B, Prior T, Zhang X, Miller R, Kolb SJ, Moore DAN, et al. An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy. Muscle Nerve. 2009;40(4):652\u20136. https:\/\/doi.org\/10.1002\/mus.21350.","journal-title":"Muscle Nerve"},{"issue":"3","key":"1339_CR48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/PEP.0000000000000515","volume":"30","author":"R Salazar","year":"2018","unstructured":"Salazar R, Montes J, Dunaway Young S, McDermott MP, Martens W, Pasternak A, et al. Quantitative evaluation of lower extremity joint contractures in spinal muscular atrophy: implications for motor function. Pediatr Phys Ther. 2018;30(3):209\u201315. https:\/\/doi.org\/10.1097\/PEP.0000000000000515.","journal-title":"Pediatr Phys Ther"},{"issue":"1","key":"1339_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5604\/15093492.933792","volume":"13","author":"A Fujak","year":"2011","unstructured":"Fujak A, Kopschina C, Gras F, Forst R, Forst J. Contractures of the lower extremities in spinal muscular atrophy type II. Descriptive clinical study with retrospective data collection. Ortop Traumatol Rehabil. 2011;13(1):27\u201336.","journal-title":"Ortop Traumatol Rehabil"},{"issue":"1","key":"1339_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00002060-199501000-00006","volume":"74","author":"TN Willig","year":"1995","unstructured":"Willig TN, Bach JR, Rouffet MJ, Krivickas LS, Maquet C. Correlation of flexion contractures with upper extremity function and pain for spinal muscular atrophy and congenital myopathy patients. Am J Phys Med Rehabil. 1995;74(1):33\u20138.","journal-title":"Am J Phys Med Rehabil"},{"issue":"11","key":"1339_CR51","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0003-9993(94)90001-9","volume":"75","author":"TN Willig","year":"1994","unstructured":"Willig TN, Paulus J, Lacau S, Guily J, B\u00e9on C, Navarro J. Swallowing problems in neuromuscular disorders. Arch Phys Med Rehabil. 1994;75(11):1175\u201381. https:\/\/doi.org\/10.1016\/0003-9993(94)90001-9.","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"1339_CR52","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.nmd.2008.02.008","volume":"18","author":"S Messina","year":"2008","unstructured":"Messina S, Pane M, De Rose P, Vasta I, Sorleti D, Aloysius A, et al. Feeding problems and malnutrition in spinal muscular atrophy type II. Neuromuscul Disord. 2008;18(5):389\u201393.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"1339_CR53","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1212\/WNL.0000000000002348","volume":"86","author":"HW van Bruggen","year":"2016","unstructured":"van Bruggen HW, Wadman RI, Bronkhorst EM, Leeuw M, Creugers N, Kalaykova SI, et al. Mandibular dysfunction as a reflection of bulbar involvement in SMA type 2 and 3. Neurology. 2016;86(6):552\u20139.","journal-title":"Neurology."},{"issue":"7","key":"1339_CR54","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.nmd.2010.05.013","volume":"20","author":"DM Sproule","year":"2010","unstructured":"Sproule DM, Montes J, Dunaway S, Montgomery M, Battista V, Koenigsberger D, et al. Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy. Neuromuscul Disord. 2010;20(7):448\u201352.","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"1339_CR55","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1469-8749.2002.tb00847.x","volume":"44","author":"BF Steffensen","year":"2002","unstructured":"Steffensen BF, Lyager S, Werge B, Rahbek J, Mattsson E. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol. 2002;44(9):623\u201332.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"1339_CR56","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1378\/chest.126.3.831","volume":"126","author":"C Ioos","year":"2004","unstructured":"Ioos C, Leclair-Richard D, Mrad S, Barois A, Estournet-Mathiaud B. Respiratory capacity course in patients with infantile spinal muscular atrophy. Chest. 2004;126(3):831\u20137. https:\/\/doi.org\/10.1378\/chest.126.3.831.","journal-title":"Chest."},{"key":"1339_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.resp.2014.03.001","volume":"197","author":"A LoMauro","year":"2014","unstructured":"LoMauro A, Romei M, Priori R, Laviola M, D'Angelo MG, Aliverti A. Alterations of thoraco-abdominal volumes and asynchronies in patients with spinal muscle atrophy type III. Respir Physiol Neurobiol. 2014;197:1\u20138. https:\/\/doi.org\/10.1016\/j.resp.2014.03.001.","journal-title":"Respir Physiol Neurobiol"},{"issue":"6","key":"1339_CR58","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ejpn.2013.04.004","volume":"17","author":"S Khirani","year":"2013","unstructured":"Khirani S, Colella M, Caldarelli V, Aubertin G, Boule M, Forin V, et al. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3. Eur J Paediatr Neurol. 2013;17(6):552\u201360. https:\/\/doi.org\/10.1016\/j.ejpn.2013.04.004.","journal-title":"Eur J Paediatr Neurol"},{"issue":"12","key":"1339_CR59","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.nmd.2015.09.009","volume":"25","author":"VA Sansone","year":"2015","unstructured":"Sansone VA, Racca F, Ottonello G, Vianello A, Berardinelli A, Crescimanno G, et al. 1st Italian SMA family association consensus meeting: management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015. Neuromuscul Disord. 2015;25(12):979\u201389. https:\/\/doi.org\/10.1016\/j.nmd.2015.09.009.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"1339_CR60","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.nmd.2017.01.018","volume":"27","author":"F Rouault","year":"2017","unstructured":"Rouault F, Christie-Brown V, Broekgaarden R, Gusset N, Henderson D, Marczuk P, et al. Disease impact on general well-being and therapeutic expectations of European type II and type III spinal muscular atrophy patients. Neuromuscul Disord. 2017;27(5):428\u201338. https:\/\/doi.org\/10.1016\/j.nmd.2017.01.018.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"1339_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/prm-160360","volume":"9","author":"S Dunaway","year":"2016","unstructured":"Dunaway S, Montes J, McDermott MP, Martens W, Neisen A, Glanzman AM, et al. Physical therapy services received by individuals with spinal muscular atrophy (SMA). J Pediatr Rehabil Med. 2016;9(1):35\u201344. https:\/\/doi.org\/10.3233\/prm-160360.","journal-title":"J Pediatr Rehabil Med"},{"issue":"6","key":"1339_CR62","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.brainresbull.2008.01.007","volume":"75","author":"F Cincotti","year":"2008","unstructured":"Cincotti F, Mattia D, Aloise F, Bufalari S, Schalk G, Oriolo G, et al. Non-invasive brain-computer interface system: towards its application as assistive technology. Brain Res Bull. 2008;75(6):796\u2013803. https:\/\/doi.org\/10.1016\/j.brainresbull.2008.01.007.","journal-title":"Brain Res Bull"},{"issue":"18","key":"1339_CR63","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1080\/01691864.2013.841311","volume":"27","author":"Y Hasegawa","year":"2013","unstructured":"Hasegawa Y, Oura S, Takahashi J. Exoskeletal meal assistance system (EMAS II) for patients with progressive muscular disease. Adv Robotics. 2013;27(18):1385\u201398. https:\/\/doi.org\/10.1080\/01691864.2013.841311.","journal-title":"Adv Robotics"},{"issue":"5","key":"1339_CR64","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/BPO.0b013e31821f50b5","volume":"31","author":"T Haumont","year":"2011","unstructured":"Haumont T, Rahman T, Sample W, King MM, Church C, Henley J, et al. Wilmington robotic exoskeleton: a novel device to maintain arm improvement in muscular disease. J Pediatr Orthop. 2011;31(5):e44\u2013e9. https:\/\/doi.org\/10.1097\/BPO.0b013e31821f50b5.","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"1339_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1017\/S0012162200000116","volume":"42","author":"M Kubota","year":"2000","unstructured":"Kubota M, Sakakihara Y, Nagata T, Nitta H, Oka A, Horio K, et al. New ocular movement detector system as a communication tool in ventilator-assisted Werdnig-Hoffmann disease. Dev Med Child Neurol. 2000;42(1):61\u20134.","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"1339_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/17483107.2010.525292","volume":"6","author":"A Fujak","year":"2011","unstructured":"Fujak A, Kopschina C, Forst R, Mueller LA, Forst J. Use of orthoses and orthopaedic technical devices in proximal spinal muscular atrophy. Results of survey in 194 SMA patients. Disabil Rehabil Assist Technol. 2011;6(4):305\u201311.","journal-title":"Disabil Rehabil Assist Technol"},{"issue":"3","key":"1339_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/JND-160168","volume":"3","author":"M Hunter","year":"2016","unstructured":"Hunter M, Heatwole C, Luebbe E, Johnson NE. What matters Most: a perspective from adult spinal muscular atrophy patients. J Neuromuscul Dis. 2016;3(3):425\u20139.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"1339_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/17518420903154093","volume":"13","author":"J Jeppesen","year":"2010","unstructured":"Jeppesen J, Madsen A, Marquardt J, Rahbek J. Living and ageing with spinal muscular atrophy type 2: observations among an unexplored patient population. Dev Neurorehabil. 2010;13(1):10\u20138. https:\/\/doi.org\/10.3109\/17518420903154093.","journal-title":"Dev Neurorehabil"},{"issue":"11","key":"1339_CR69","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1111\/jan.13042","volume":"72","author":"HM Ho","year":"2016","unstructured":"Ho HM, Tseng YH, Hsin YM, Chou FH, Lin WT. Living with illness and self-transcendence: the lived experience of patients with spinal muscular atrophy. J Adv Nurs. 2016;72(11):2695\u2013705. https:\/\/doi.org\/10.1111\/jan.13042.","journal-title":"J Adv Nurs"},{"issue":"4","key":"1339_CR70","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/01376517-200808000-00009","volume":"40","author":"C Lamb","year":"2008","unstructured":"Lamb C, Peden A. Understanding the experience of living with spinal muscular atrophy: a qualitative description. J Neurosci Nurs. 2008;40(4):250\u20136. https:\/\/doi.org\/10.1097\/01376517-200808000-00009.","journal-title":"J Neurosci Nurs"},{"issue":"4","key":"1339_CR71","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/jnd-150101","volume":"2","author":"J Montes","year":"2015","unstructured":"Montes J, Garber CE, Kramer SS, Montgomery MJ, Dunaway S, Kamil-Rosenberg S, et al. Single-blind, randomized, controlled clinical trial of exercise in ambulatory spinal muscular atrophy: why are the results negative? J Neuromuscul Dis. 2015;2(4):463\u201370. https:\/\/doi.org\/10.3233\/jnd-150101.","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"1339_CR72","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/mus.24527","volume":"52","author":"KL Madsen","year":"2015","unstructured":"Madsen KL, Hansen RS, Preisler N, Th\u00f8gersen F, Berthelsen MP, Vissing J. Training improves oxidative capacity, but not function, in spinal muscular atrophy type III. Muscle Nerve. 2015;52(2):240\u20134. https:\/\/doi.org\/10.1002\/mus.24527.","journal-title":"Muscle Nerve"},{"issue":"3","key":"1339_CR73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0003-9993(95)80603-2","volume":"76","author":"JR Bach","year":"1995","unstructured":"Bach JR, Wang TG. Noninvasive long-term ventilatory support for individuals with spinal muscular atrophy and functional bulbar musculature. Arch Phys Med Rehabil. 1995;76(3):213\u20137.","journal-title":"Arch Phys Med Rehabil"},{"key":"1339_CR74","doi-asserted-by":"publisher","unstructured":"Ward K, Ford V, Ashcroft H, Parker R. Intermittent daytime mouthpiece ventilation successfully augments nocturnal non-invasive ventilation, controlling ventilatory failure and maintaining patient independence. BMJ Case Rep. 2015;2015. https:\/\/doi.org\/10.1136\/bcr-2015-209716.","DOI":"10.1136\/bcr-2015-209716"},{"issue":"6","key":"1339_CR75","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/qjmed\/89.6.469","volume":"89","author":"RM Chalmers","year":"1996","unstructured":"Chalmers RM, Howard RS, Wiles CM, Hirsch NP, Miller DH, Williams A, et al. Respiratory insufficiency in neuronopathic and neuropathic disorders. QJM. 1996;89(6):469\u201376.","journal-title":"QJM."},{"issue":"3","key":"1339_CR76","first-page":"E98","volume":"57","author":"M Katayama","year":"2011","unstructured":"Katayama M, Naritomi H, Nishio H, Watanabe T, Teramoto S, Kanda F, et al. Long-term stabilization of respiratory conditions in patients with spinal muscular atrophy type 2 by continuous positive airway pressure: a report of two cases. Kobe J Med Sci. 2011;57(3):E98\u2013105.","journal-title":"Kobe J Med Sci"},{"issue":"3","key":"1339_CR77","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00002060-199406000-00010","volume":"73","author":"TG Wang","year":"1994","unstructured":"Wang TG, Bach JR, Avilla C, Alba AS, Yang GF. Survival of individuals with spinal muscular atrophy on ventilatory support. Am J Phys Med Rehabil. 1994;73(3):207\u201311.","journal-title":"Am J Phys Med Rehabil"},{"issue":"3","key":"1339_CR78","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpeds.2011.08.016","volume":"160","author":"Y-S Chen","year":"2012","unstructured":"Chen Y-S, Shih H-H, Chen T-H, Kuo C-H, Jong Y-J. Prevalence and risk factors for feeding and swallowing difficulties in spinal muscular atrophy types II and III. J Pediatr. 2012;160(3):447\u201351 e1.","journal-title":"J Pediatr"},{"issue":"3","key":"1339_CR79","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00455-009-9269-1","volume":"25","author":"TH Cha","year":"2010","unstructured":"Cha TH, Oh DW, Shim JH. Noninvasive treatment strategy for swallowing problems related to prolonged nonoral feeding in spinal muscular atrophy type II. Dysphagia. 2010;25(3):261\u20134. https:\/\/doi.org\/10.1007\/s00455-009-9269-1.","journal-title":"Dysphagia."},{"issue":"2","key":"1339_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/mus.23904","volume":"49","author":"JT Kissel","year":"2014","unstructured":"Kissel JT, Elsheikh B, King WM, Freimer M, Scott CB, Kolb SJ, et al. SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy. Muscle Nerve. 2014;49(2):187\u201392. https:\/\/doi.org\/10.1002\/mus.23904.","journal-title":"Muscle Nerve"},{"issue":"2","key":"1339_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/ncn3.140","volume":"3","author":"T Saito","year":"2015","unstructured":"Saito T, Nurputra DK, Harahap NIF, Harahap ISK, Yamamoto H, Muneshige E, et al. A study of valproic acid for patients with spinal muscular atrophy. Neurol Clin Neurosci. 2015;3(2):49\u201357. https:\/\/doi.org\/10.1111\/ncn3.140.","journal-title":"Neurol Clin Neurosci"},{"issue":"3","key":"1339_CR82","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","volume":"67","author":"CC Weihl","year":"2006","unstructured":"Weihl CC, Connolly AM, Pestronk A. Valproate may improve strength and function in patients with type III\/IV spinal muscle atrophy. Neurology. 2006;67(3):500\u20131. https:\/\/doi.org\/10.1212\/01.wnl.0000231139.26253.d0.","journal-title":"Neurology."},{"issue":"8","key":"1339_CR83","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1177\/08830738030180080501","volume":"18","author":"L Merlini","year":"2003","unstructured":"Merlini L, Solari A, Vita G, Bertini E, Minetti C, Mongini T, et al. Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study. J Child Neurol. 2003;18(8):537\u201341. https:\/\/doi.org\/10.1177\/08830738030180080501.","journal-title":"J Child Neurol"},{"issue":"1\u20132","key":"1339_CR84","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-510X(01)00632-3","volume":"191","author":"RG Miller","year":"2001","unstructured":"Miller RG, Moore DH, Dronsky V, Bradley W, Barohn R, Bryan W, et al. A placebo-controlled trial of gabapentin in spinal muscular atrophy. J Neurol Sci. 2001;191(1\u20132):127\u201331.","journal-title":"J Neurol Sci"},{"issue":"24","key":"1339_CR85","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1212\/WNL.0b013e3182020332","volume":"75","author":"TH Chen","year":"2010","unstructured":"Chen TH, Chang JG, Yang YH, Mai HH, Liang WC, Wu YC, et al. Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy. Neurology. 2010;75(24):2190\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e3182020332.","journal-title":"Neurology."},{"issue":"5","key":"1339_CR86","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/jmedgenet-2018-105482","volume":"56","author":"FD Tiziano","year":"2019","unstructured":"Tiziano FD, Lomastro R, Abiusi E, Pasanisi MB, Di Pietro L, Fiori S, et al. Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol. J Med Genet. 2019;56(5):293\u2013300. https:\/\/doi.org\/10.1136\/jmedgenet-2018-105482.","journal-title":"J Med Genet"},{"issue":"5","key":"1339_CR87","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/mus.25102","volume":"54","author":"AM Giovannetti","year":"2016","unstructured":"Giovannetti AM, Pasanisi MB, Cerniauskaite M, Bussolino C, Leonardi M, Morandi L. Perceived efficacy of salbutamol by persons with spinal muscular atrophy: a mixed methods study. Muscle Nerve. 2016;54(5):843\u20139. https:\/\/doi.org\/10.1002\/mus.25102.","journal-title":"Muscle Nerve"},{"issue":"4","key":"1339_CR88","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/jnd-190416","volume":"6","author":"MC Walter","year":"2019","unstructured":"Walter MC, Wenninger S, Thiele S, Stauber J, Hiebeler M, Greckl E, et al. Safety and treatment effects of Nusinersen in longstanding adult 5q-SMA type 3 - a prospective observational study. J Neuromuscul Dis. 2019;6(4):453\u201365. https:\/\/doi.org\/10.3233\/jnd-190416.","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"1339_CR89","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/mus.26769","volume":"61","author":"A Veerapandiyan","year":"2020","unstructured":"Veerapandiyan A, Eichinger K, Guntrum D, Kwon J, Baker L, Collins E, et al. Nusinersen for older patients with spinal muscular atrophy: a real-world clinical setting experience. Muscle Nerve. 2020;61(2):222\u20136. https:\/\/doi.org\/10.1002\/mus.26769.","journal-title":"Muscle Nerve"},{"key":"1339_CR90","doi-asserted-by":"publisher","first-page":"175628641880324","DOI":"10.1177\/1756286418803246","volume":"11","author":"B Stolte","year":"2018","unstructured":"Stolte B, Totzeck A, Kizina K, Bolz S, Pietruck L, Monninghoff C, et al. Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy. Ther Adv Neurol Disord. 2018;11:1756286418803246. https:\/\/doi.org\/10.1177\/1756286418803246.","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"1339_CR91","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3174\/ajnr.A6351","volume":"41","author":"JP Jacobson","year":"2020","unstructured":"Jacobson JP, Cristiano BC, Hoss DR. Simple fluoroscopy-guided transforaminal lumbar puncture: safety and effectiveness of a coaxial curved-needle technique in patients with spinal muscular atrophy and complex spines. AJNR Am J Neuroradiol. 2020;41(1):183\u20138. https:\/\/doi.org\/10.3174\/ajnr.A6351.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1339_CR92","doi-asserted-by":"publisher","unstructured":"Ko D, Blatt D, Karam C, Gupta K, Raslan AM. Lumbar laminotomy for the intrathecal administration of nusinersen for spinal muscular atrophy: technical note and outcomes. J Neurosurg Spine. 2019:1\u20135. https:\/\/doi.org\/10.3171\/2019.2.Spine181366.","DOI":"10.3171\/2019.2.Spine181366"},{"issue":"10","key":"1339_CR93","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.nmd.2019.08.007","volume":"29","author":"S Bortolani","year":"2019","unstructured":"Bortolani S, Stura G, Ventilii G, Vercelli L, Rolle E, Ricci F, et al. Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach. Neuromuscul Disord. 2019;29(10):742\u20136. https:\/\/doi.org\/10.1016\/j.nmd.2019.08.007.","journal-title":"Neuromuscul Disord"},{"key":"1339_CR94","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3389\/fneur.2019.01166","volume":"10","author":"K Kizina","year":"2019","unstructured":"Kizina K, Stolte B, Totzeck A, Bolz S, Fleischer M, Monninghoff C, et al. Clinical implication of dosimetry of computed tomography- and fluoroscopy-guided intrathecal therapy with nusinersen in adult patients with spinal muscular atrophy. Front Neurol. 2019;10:1166. https:\/\/doi.org\/10.3389\/fneur.2019.01166.","journal-title":"Front Neurol"},{"issue":"1","key":"1339_CR95","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00415-018-9124-0","volume":"266","author":"CD Wurster","year":"2018","unstructured":"Wurster CD, Winter B, Wollinsky K, Ludolph AC, Uzelac Z, Witzel S, et al. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients. J Neurol. 2018;266(1):183\u201394. https:\/\/doi.org\/10.1007\/s00415-018-9124-0.","journal-title":"J Neurol"},{"issue":"2","key":"1339_CR96","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nmd.2016.11.011","volume":"27","author":"A Hiscock","year":"2017","unstructured":"Hiscock A, Kuhn I, Barclay S. Advance care discussions with young people affected by life-limiting neuromuscular diseases: a systematic literature review and narrative synthesis. Neuromuscul Disord. 2017;27(2):115\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"1339_CR97","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1440-1754.1999.00351.x","volume":"35","author":"D Parker","year":"1999","unstructured":"Parker D, Maddocks I, Stern LM. The role of palliative care in advanced muscular dystrophy and spinal muscular atrophy. J Paediatr Child Health. 1999;35(3):245\u201350.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"1339_CR98","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1055\/s-0034-1395348","volume":"46","author":"F Bianco","year":"2015","unstructured":"Bianco F, Pane M, D'Amico A, Messina S, Delogu AB, Soraru G, et al. Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? Neuropediatrics. 2015;46(1):33\u20136. https:\/\/doi.org\/10.1055\/s-0034-1395348.","journal-title":"Neuropediatrics."},{"issue":"3","key":"1339_CR99","first-page":"175","volume":"30","author":"A Palladino","year":"2011","unstructured":"Palladino A, Passamano L, Taglia A, D'Ambrosio P, Scutifero M, Cecio MR, et al. Cardiac involvement in patients with spinal muscular atrophies. Acta Myol. 2011;30(3):175\u20138.","journal-title":"Acta Myol"},{"issue":"2","key":"1339_CR100","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejogrb.2012.02.020","volume":"162","author":"C Awater","year":"2012","unstructured":"Awater C, Zerres K, Rudnik-Schoneborn S. Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):153\u20139. https:\/\/doi.org\/10.1016\/j.ejogrb.2012.02.020.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"1339_CR101","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/01443619750113708","volume":"17","author":"A Coker","year":"1997","unstructured":"Coker A, Scott W, McCune G. Antenatal care and delivery of a patient with spinal muscular atrophy complicated with severe kyphoscsoliosis. J Obstet Gynaecol. 1997;17(2):154\u20135.","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"1339_CR102","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/01.PHM.0000046621.00871.30","volume":"82","author":"R Yim","year":"2003","unstructured":"Yim R, Kirschner K, Murphy E, Parson J, Winslow C. Successful pregnancy in a patient with spinal muscular atrophy and severe kyphoscoliosis. Am J Phys Med Rehabil. 2003;82(3):222\u20135. https:\/\/doi.org\/10.1097\/01.PHM.0000046621.00871.30.","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"1339_CR103","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/bf00839207","volume":"239","author":"S Rudnik-Sch\u00f6neborn","year":"1992","unstructured":"Rudnik-Sch\u00f6neborn S, Zerres K, Ignatius J, Rietschel M. Pregnancy and spinal muscular atrophy. J Neurol. 1992;239(1):26\u201330. https:\/\/doi.org\/10.1007\/bf00839207.","journal-title":"J Neurol"},{"issue":"3","key":"1339_CR104","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00004356-199709000-00003","volume":"20","author":"F Andries","year":"1997","unstructured":"Andries F, Wevers CWJ, Wintzen AR, Busch HFM, H\u00f6weler CJ, De Jager AEJ, et al. Vocational perspectives and neuromuscular disorders. Int J Rehabil Res. 1997;20(3):255\u201373.","journal-title":"Int J Rehabil Res"},{"issue":"5","key":"1339_CR105","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/mus.25148","volume":"54","author":"ET Kruitwagen-Van Reenen","year":"2016","unstructured":"Kruitwagen-Van Reenen ET, Wadman RI, Visser-Meily JM, van den Berg LH, Schroder C, van der Pol WL. Correlates of health related quality of life in adult patients with spinal muscular atrophy. Muscle Nerve. 2016;54(5):850\u20135. https:\/\/doi.org\/10.1002\/mus.25148.","journal-title":"Muscle Nerve"},{"issue":"12","key":"1339_CR106","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.nmd.2017.09.003","volume":"27","author":"A Bergsma","year":"2017","unstructured":"Bergsma A, Janssen MMHP, Geurts ACH, Cup EHC, de Groot IJM. Different profiles of upper limb function in four types of neuromuscular disorders. Neuromuscul Disord. 2017;27(12):1115\u201322. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.003.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1339_CR107","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pjnns.2017.10.007","volume":"52","author":"K Bienias","year":"2018","unstructured":"Bienias K, \u015acibek J, Cegielska J, Kochanowski J. Evaluation of activities of daily living in patients with slowly progressive neuromuscular diseases. Neurol Neurochir Pol. 2018;52(2):222\u20137. https:\/\/doi.org\/10.1016\/j.pjnns.2017.10.007.","journal-title":"Neurol Neurochir Pol"},{"key":"1339_CR108","doi-asserted-by":"publisher","unstructured":"Fischer MJ, Asselman FL, Kruitwagen-van Reenen ET, Verhoef M, Wadman RI, Visser-Meily JMA, et al. Psychological well-being in adults with spinal muscular atrophy: the contribution of participation and psychological needs. Disabil Rehabil. 2019:1\u20139. https:\/\/doi.org\/10.1080\/09638288.2018.1555864.","DOI":"10.1080\/09638288.2018.1555864"},{"issue":"1","key":"1339_CR109","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12883-017-0853-y","volume":"17","author":"S McGraw","year":"2017","unstructured":"McGraw S, Qian Y, Henne J, Jarecki J, Hobby K, Yeh W-S. A qualitative study of perceptions of meaningful change in spinal muscular atrophy. BMC Neurol. 2017;17(1):68. https:\/\/doi.org\/10.1186\/s12883-017-0853-y.","journal-title":"BMC Neurol"},{"issue":"1","key":"1339_CR110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/104990910201900109","volume":"19","author":"RT Abresch","year":"2002","unstructured":"Abresch RT, Carter GT, Jensen MP, Kilmer DD. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care. 2002;19(1):39\u201348. https:\/\/doi.org\/10.1177\/104990910201900109.","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"1339_CR111","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/mus.26201","volume":"58","author":"ET Kruitwagen-van Reenen","year":"2018","unstructured":"Kruitwagen-van Reenen ET, van der Pol L, Schroder C, Wadman RI, van den Berg LH, Visser-Meily JMA, et al. Social participation of adult patients with spinal muscular atrophy: frequency, restrictions, satisfaction and correlates. Muscle Nerve. 2018;58(6):805\u201311. https:\/\/doi.org\/10.1002\/mus.26201.","journal-title":"Muscle Nerve"},{"key":"1339_CR112","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3389\/fneur.2019.01098","volume":"10","author":"R Gunther","year":"2019","unstructured":"Gunther R, Wurster CD, Cordts I, Koch JC, Kamm C, Petzold D, et al. Patient-reported prevalence of non-motor symptoms is low in adult patients suffering from 5q spinal muscular atrophy. Front Neurol. 2019;10:1098. https:\/\/doi.org\/10.3389\/fneur.2019.01098.","journal-title":"Front Neurol"},{"issue":"1","key":"1339_CR113","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10897-017-0122-7","volume":"27","author":"FK Boardman","year":"2018","unstructured":"Boardman FK, Young PJ, Griffiths FE. Impairment experiences, identity and attitudes towards genetic screening: the views of people with spinal muscular atrophy. J Genet Couns. 2018;27(1):69\u201384.","journal-title":"J Genet Couns"},{"issue":"2","key":"1339_CR114","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0738-3991(94)90007-8","volume":"24","author":"JCM van Haastregt","year":"1994","unstructured":"van Haastregt JCM, de Witte LP, Terpstra SJ, Diederiks JPM, van der Horst FGEM, de Geus CA. Membership of a patients' association and well-being a study into the relationship between membership of a patients' association, fellow-patient contact, information received, and psychosocial well-being of people with a neuromuscular disease. Patient Educ Couns. 1994;24(2):135\u201348. https:\/\/doi.org\/10.1016\/0738-3991(94)90007-8.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"1339_CR115","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/jnd-180342","volume":"6","author":"S Dunaway Young","year":"2018","unstructured":"Dunaway Young S, Montes J, Kramer SS, Podwika B, Rao AK, De Vivo DC. Perceived fatigue in spinal muscular atrophy: a pilot study. J Neuromuscul Dis. 2018;6(1):109\u201317. https:\/\/doi.org\/10.3233\/jnd-180342.","journal-title":"J Neuromuscul Dis"},{"key":"1339_CR116","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12883-015-0473-3","volume":"15","author":"Y Qian","year":"2015","unstructured":"Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh W. Understanding the experiences and needs of individuals with spinal muscular atrophy and their parents: a qualitative study. BMC Neurol. 2015;15:217. https:\/\/doi.org\/10.1186\/s12883-015-0473-3.","journal-title":"BMC Neurol"},{"issue":"1","key":"1339_CR117","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13023-019-1052-2","volume":"14","author":"HWY Wan","year":"2019","unstructured":"Wan HWY, Carey KA, D'Silva A, Kasparian NA, Farrar MA. \u201cGetting ready for the adult world\u201d: how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being. Orphanet J Rare Dis. 2019;14(1):74. https:\/\/doi.org\/10.1186\/s13023-019-1052-2.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1339_CR118","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/1363459313507588","volume":"18","author":"F Boardman","year":"2014","unstructured":"Boardman F. Experiential knowledge of disability, impairment and illness: the reproductive decisions of families genetically at risk. Health. 2014;18(5):476\u201392. https:\/\/doi.org\/10.1177\/1363459313507588.","journal-title":"Health."},{"issue":"1","key":"1339_CR119","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-016-0424-0","volume":"11","author":"C Klug","year":"2016","unstructured":"Klug C, Schreiber-Katz O, Thiele S, Schorling E, Zowe J, Reilich P, et al. Disease burden of spinal muscular atrophy in Germany. Orphanet J Rare Dis. 2016;11(1):58.","journal-title":"Orphanet J Rare Dis"},{"key":"1339_CR120","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fneur.2019.00898","volume":"10","author":"DST Kariyawasam","year":"2019","unstructured":"Kariyawasam DST, D'Silva A, Lin C, Ryan MM, Farrar MA. Biomarkers and the development of a personalized medicine approach in spinal muscular atrophy. Front Neurol. 2019;10:898. https:\/\/doi.org\/10.3389\/fneur.2019.00898.","journal-title":"Front Neurol"},{"issue":"11","key":"1339_CR121","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","volume":"29","author":"DC De Vivo","year":"2019","unstructured":"De Vivo DC, Bertini E, Swoboda KJ, Hwu WL, Crawford TO, Finkel RS, et al. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the phase 2 NURTURE study. Neuromuscul Disord. 2019;29(11):842\u201356. https:\/\/doi.org\/10.1016\/j.nmd.2019.09.007.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"1339_CR122","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/acn3.406","volume":"4","author":"U Bonati","year":"2017","unstructured":"Bonati U, Holiga S, Hellbach N, Risterucci C, Bergauer T, Tang W, et al. Longitudinal characterization of biomarkers for spinal muscular atrophy. Ann Clin Transl Neurol. 2017;4(5):292\u2013304. https:\/\/doi.org\/10.1002\/acn3.406.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1339_CR123","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00415-019-09547-y","volume":"267","author":"CD Wurster","year":"2020","unstructured":"Wurster CD, Steinacker P, Gunther R, Koch JC, Lingor P, Uzelac Z, et al. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen. J Neurol. 2020;267(1):36\u201344. https:\/\/doi.org\/10.1007\/s00415-019-09547-y.","journal-title":"J Neurol"},{"key":"1339_CR124","doi-asserted-by":"publisher","first-page":"175628641984605","DOI":"10.1177\/1756286419846058","volume":"12","author":"CD Wurster","year":"2019","unstructured":"Wurster CD, Gunther R, Steinacker P, Dreyhaupt J, Wollinsky K, Uzelac Z, et al. Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment. Ther Adv Neurol Disord. 2019;12:1756286419846058. https:\/\/doi.org\/10.1177\/1756286419846058.","journal-title":"Ther Adv Neurol Disord"},{"key":"1339_CR125","doi-asserted-by":"publisher","unstructured":"Totzeck A, Stolte B, Kizina K, Bolz S, Schlag M, Thimm A, et al. Neurofilament heavy chain and tau protein are not elevated in cerebrospinal fluid of adult patients with spinal muscular atrophy during loading with Nusinersen. Int J Mol Sci. 2019;20(21). https:\/\/doi.org\/10.3390\/ijms20215397.","DOI":"10.3390\/ijms20215397"},{"issue":"6","key":"1339_CR126","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/ejhg.2012.233","volume":"21","author":"FD Tiziano","year":"2013","unstructured":"Tiziano FD, Lomastro R, Di Pietro L, Pasanisi MB, Fiori S, Angelozzi C, et al. Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study. Eur J Hum Genet. 2013;21(6):630\u20136. https:\/\/doi.org\/10.1038\/ejhg.2012.233.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"1339_CR127","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24864","volume":"81","author":"MA Farrar","year":"2017","unstructured":"Farrar MA, Park SB, Vucic S, Carey KA, Turner BJ, Gillingwater TH, et al. Emerging therapies and challenges in spinal muscular atrophy. Ann Neurol. 2017;81(3):355\u201368. https:\/\/doi.org\/10.1002\/ana.24864.","journal-title":"Ann Neurol"},{"issue":"6","key":"1339_CR128","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/adc.2010.202473","volume":"96","author":"R Crowley","year":"2011","unstructured":"Crowley R, Wolfe I, Lock K, McKee M. Improving the transition between paediatric and adult healthcare: a systematic review. Arch Dis Child. 2011;96(6):548. https:\/\/doi.org\/10.1136\/adc.2010.202473.","journal-title":"Arch Dis Child"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-1339-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:05:41Z","timestamp":1615511141000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-1339-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-1339-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"16 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MF has served on the scientific advisory board for Biogen. SV has received honoraria from Merck Serono Australia. MK is the Editor-in-Chief Journal of Neurology, Neurosurgery & Psychiatry (BMJ Publishing Group, UK); 2010-present. HW, AD, KC, NK report no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}